493 related articles for article (PubMed ID: 12615726)
21. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma.
Kawahara N; Ono M; Taguchi K; Okamoto M; Shimada M; Takenaka K; Hayashi K; Mosher DF; Sugimachi K; Tsuneyoshi M; Kuwano M
Hepatology; 1998 Dec; 28(6):1512-7. PubMed ID: 9828214
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars.
Hakvoort T; Altun V; van Zuijlen PP; de Boer WI; van Schadewij WA; van der Kwast TH
Eur Cytokine Netw; 2000 Jun; 11(2):233-39. PubMed ID: 10903802
[TBL] [Abstract][Full Text] [Related]
23. Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis.
Kang Y; Hebron H; Ozbun L; Mariano J; Minoo P; Jakowlew SB
Mol Carcinog; 2004 Aug; 40(4):212-31. PubMed ID: 15264213
[TBL] [Abstract][Full Text] [Related]
24. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction.
Masui T; Hosotani R; Doi R; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Tulachan SS; Imamura M
Anticancer Res; 2002; 22(6C):4093-100. PubMed ID: 12553038
[TBL] [Abstract][Full Text] [Related]
25. [Vascular endothelial growth factor gene expression in nasopharyngeal carcinoma cell line induced by hypoxia in vitro].
Yang HF; Tang WP
Ai Zheng; 2003 Feb; 22(2):160-3. PubMed ID: 12600291
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
[TBL] [Abstract][Full Text] [Related]
27. Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization.
Fukuzawa M; Sugiura H; Koshinaga T; Ikeda T; Hagiwara N; Sawada T
J Pediatr Surg; 2002 Dec; 37(12):1747-50. PubMed ID: 12483647
[TBL] [Abstract][Full Text] [Related]
28. The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells.
Pollmann C; Huang X; Mall J; Bech-Otschir D; Naumann M; Dubiel W
Cancer Res; 2001 Dec; 61(23):8416-21. PubMed ID: 11731421
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor is expressed in human fetal growth cartilage.
Garcia-Ramirez M; Toran N; Andaluz P; Carrascosa A; Audi L
J Bone Miner Res; 2000 Mar; 15(3):534-40. PubMed ID: 10750568
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.
Gille J; Swerlick RA; Caughman SW
EMBO J; 1997 Feb; 16(4):750-9. PubMed ID: 9049304
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
32. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
33. Triptolide inhibits vascular endothelial growth factor expression and production in endothelial cells.
Hu KB; Liu ZH; Guo XH; Liu D; Li LS
Acta Pharmacol Sin; 2001 Jul; 22(7):651-6. PubMed ID: 11749832
[TBL] [Abstract][Full Text] [Related]
34. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.
Stevens A; Soden J; Brenchley PE; Ralph S; Ray DW
Cancer Res; 2003 Feb; 63(4):812-6. PubMed ID: 12591731
[TBL] [Abstract][Full Text] [Related]
35. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
Hyder SM; Nawaz Z; Chiappetta C; Stancel GM
Cancer Res; 2000 Jun; 60(12):3183-90. PubMed ID: 10866309
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.
Barbera-Guillem E; Nyhus JK; Wolford CC; Friece CR; Sampsel JW
Cancer Res; 2002 Dec; 62(23):7042-9. PubMed ID: 12460925
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of vascular endothelial growth factor in human skeletal muscle in response to short-term one-legged exercise training.
Gustafsson T; Knutsson A; Puntschart A; Kaijser L; Nordqvist AC; Sundberg CJ; Jansson E
Pflugers Arch; 2002 Sep; 444(6):752-9. PubMed ID: 12355175
[TBL] [Abstract][Full Text] [Related]
39. Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes.
Seko Y; Seko Y; Takahashi N; Shibuya M; Yazaki Y
Biochem Biophys Res Commun; 1999 Jan; 254(2):462-5. PubMed ID: 9918861
[TBL] [Abstract][Full Text] [Related]
40. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
